e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
The new classification system of nonsmall cell lung cancer: a challenge for imaging
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correct measurement of tumour and lymph node size with CT: is it feasible?
J. Verschakelen (Leuven, Belgium)
Source:
Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging
Session:
The new classification system of nonsmall cell lung cancer: a challenge for imaging
Session type:
Symposium
Number:
4615
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Verschakelen (Leuven, Belgium). Correct measurement of tumour and lymph node size with CT: is it feasible?. Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?
Source: Eur Respir J 2007; 30: Suppl. 51, 452s
Year: 2007
What is the added diagnostic yield of mediastinoscopy following nondiagnostic EBUS-TBNA thoracic lymph node sampling?
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020
EBUS strain elastography for predicting lymph node malignancy: standardization of assessment technique
Source: International Congress 2019 – Use of thoracic ultrasound to diagnose lung diseases
Year: 2019
Location of three mediastinal lymph node stations in a three-dimensional model.
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Rotation Aiding (RA’s) technique for EBUS-TBNA biopsy of intrathoracic lymph node: a comparison of conventional Jab method
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018
Is there any added value of EBUS-TBNA to the identification of non-avid PET-CT lymph nodes?
Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Year: 2018
Assessing the value of EBUS to dismiss mediastinal node malignancy.
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019
EBUS elastography for rapid on site lymph node evaluation; A useful tool?
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
The diagnostic value of EBUS-TBNA for small mediastinal and hilar lymph nodes.
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018
EBUS guided trans-bronchial lymph node cryobiopsy (EBUS-TBLNC): A novel technique for lymph node biopsy
Source: Virtual Congress 2021 – Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound
Year: 2021
Probability model for malignancy in hilar and mediastinal lymph nodes in lung cancer based on PET-CT and EBUS
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019
Endobronchial ultrasound for assessment of positive pet lung lymph intrathorarical node
Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer
Year: 2010
Lymph node micrometastases (LNMM) in lung cancer: in which position are they relevant, and how can they be detected easily?
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Mediastinoscopy after negative endoscopic mediastinal nodal staging: can it be omitted?
Source: Eur Respir J 2015; 46: 1848-1849
Year: 2015
Mediastinoscopy after negative endoscopic mediastinal nodal staging: can it be omitted?
Source: Eur Respir J 2015; 46: 1846-1848
Year: 2015
Enlarged mediastinal lymph nodes in patients without a diagnosis; consider EUS-FNA!
Source: Eur Respir J 2003; 22: Suppl. 45, 57s
Year: 2003
The role of lymph node standard 18-FDG uptake value and lymph node-primary focus SUVmax ratio in mediastinal staging of NSCLC
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Mediastinal Lymph node echographic morphology for the prediction of malignancy in EBUS-TBNA
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Initial EBUS guided TBNA is the most cost-effective means of lymph node staging - a German experience
Source: Eur Respir J 2003; 22: Suppl. 45, 205s
Year: 2003
Do sonographic features of lymph nodes predict the anthracotic benign pathology in ex-coalminers with PET positive lymph nodes?
Source: International Congress 2017 – EBUS
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept